Emerging within the UK, retatrutide, a innovative molecule, is generating considerable buzz within the healthcare community regarding its potential for weight management . This dual GIP and GLP-1 receptor agonist appears to provide a significant improvement over existing therapies, showing promising results in initial clinical assessments. Research